Detalhe da pesquisa
1.
2-Alkyloxazoles as potent and selective PI4KIIIß inhibitors demonstrating inhibition of HCV replication.
Bioorg Med Chem Lett
; 24(16): 3714-8, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25065492
2.
A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target.
Proc Natl Acad Sci U S A
; 108(52): 21052-6, 2011 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160684
3.
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.
Clin Ther
; 40(9): 1567-1581.e4, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185394
4.
A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial.
ACS Infect Dis
; 3(2): 144-151, 2017 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27788579
5.
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors.
J Med Chem
; 45(2): 321-32, 2002 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-11784137
6.
Methods to Circumvent a Difficult Coupling in the Solid-Phase Synthesis of Cyclosporine Analogues.
J Org Chem
; 63(17): 5734-5735, 1998 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-11672164
7.
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4.
Bioorg Med Chem Lett
; 16(13): 3504-9, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16644217